Immune-mediated inflammatory diseases (IMIDs) encompass several entities such as
“classic” autoimmune disorders or immune-mediated diseases with autoinflammatory …

Extracellular vesicles (EVs) are nanoparticles released from various cell types that have
emerged as powerful new therapeutic option for a variety of diseases. EVs are involved in …

Abstract Type 1 diabetes (T1D), which is a chronic autoimmune disease, results from the
destruction of insulin‐producing β cells targeted by autoreactive T cells. The recent …

Extracellular vesicles (EVs) play an essential part in multiple pathophysiological processes
including tissue injury and regeneration because of their inherent characteristics of small …

Kidney transplantation significantly enhances the survival rate and quality of life of patients
with end-stage kidney disease. The ability to predict post-transplantation rejection events in …

Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal/stem cells
(ADSC-EVs) have demonstrated promising potential in wound healing treatment. To …

The quality of life for millions of people around the world is severely diminished by the
crippling symptoms of inflammatory bowel diseases (IBD), such as Ulcerative Colitis (UC) …

Background Cancer, as a complex, heterogeneous disease, is currently affecting millions of
people worldwide. Even if the most common traditional treatments, namely, chemotherapy …

Background Exosomes are the smallest group of extracellular vesicles in size from 30 to 150
nm, surrounded by a lipid bilayer membrane, and originate from multivesicular bodies …

Diabetes, characterized by hyperglycemia, is a major cause of death and disability
worldwide. Peptides, such as insulin and glucagon-like peptide-1 (GLP-1) analogs, have …